The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., La Fata, V., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,839
Quinn, M. T., Parthasarathy, S., Fong, L. G., & Steinberg, D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.9.2995 · Cited by 1,137
Simvastatin, an HMG–Coenzyme A Reductase Inhibitor, Improves Endothelial Function Within 1 Month
O'Driscoll, G., Green, D., & Taylor, R. R. (1997) · Circulation · doi:10.1161/01.cir.95.5.1126 · Cited by 952
Hernández-Perera, O., Pérez-Sala, D., Navarro-Antolín, J., Sánchez-Pascuala, R., Hernández, G., Díaz, C., & Lamas, S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1500 · Cited by 763
Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study
Modification of Diet in Renal Disease Study Group, Hunsicker, L. G., Adler, S., Caggiula, A., England, B. K., Greene, T., Kusek, J. W., Rogers, N. L., Teschan, P. E., & Beck, G. (1997) · Kidney International · doi:10.1038/ki.1997.260 · Cited by 702
Effect of lipid reduction on the progression of renal disease: A meta-analysis
Fried, L. F., Orchard, T. J., & Kasiske, B. L. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00487.x · Cited by 672
Ravid, M., Brosh, D., Ravid-Safran, D., Levy, Z., & Rachmani, R. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.9.998 · Cited by 452
Guijarro, C., Blanco-Colio, L. M., Ortego, M., Alonso, C., Ortiz, A., Plaza, J. J., Díaz, C., Hernández, G., & Egido, J. (1998) · Circulation Research · doi:10.1161/01.res.83.5.490 · Cited by 390
The increased risk of coronary heart disease associated with nephrotic syndrome
Ordoñez, J. D., Hiatt, R. A., Killebrew, E. J., & Fireman, B. H. (1993) · Kidney International · doi:10.1038/ki.1993.292 · Cited by 296
Abnormalities of Lipoprotein Metabolism in Patients with the Nephrotic Syndrome
Joven, J., Villabona, C., Vilella, E., Masana, L., Albertí, R., & Vallés, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230905 · Cited by 292
Samuelsson, O., Mulec, H., Knight-Gibson, C., Attman, P., Kron, B., Larrson, R., Weiss, L., Wedel, H., & Alaupovic, P. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.9.1908 · Cited by 234
Lipid Abnormalities in the Nephrotic Syndrome: Causes, Consequences, and Treatment
Wheeler, D. C., & Bernard, D. B. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80994-2 · Cited by 194
Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell, M. P., Kasiske, B. L., Kim, Y., Atluru, D., & Keane, W. F. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116204 · Cited by 168
LDL stimulates mesangial fibronectin production and chemoattractant expression
Rovin, B. H., & Tan, L. C. (1993) · Kidney International · doi:10.1038/ki.1993.35 · Cited by 152
Recent advances in statins and the kidney
Oda, H., & Keane, W. F. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.07101.x · Cited by 150
Savill, J. (1994) · Journal of the American Society of Nephrology · doi:10.1681/asn.v5112 · Cited by 144
Krolewski, A. S., Warram, J. H., & Christlieb, A. R. (1994) · PubMed · Cited by 137
Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases
Takemura, T., Yoshioka, K., Aya, N., Murakami, K., Matumoto, A., Itakura, H., Kodama, T., Suzuki, H., & Maki, S. (1993) · Kidney International · doi:10.1038/ki.1993.129 · Cited by 127
Effect of Pravastatin on Proteinuria in Patients With Well-Controlled Hypertension
Lee, T., Su, S.-F., & Tsai, C. (2002) · Hypertension · doi:10.1161/01.hyp.0000022805.11288.7f · Cited by 113
Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro
Coritsidis, G., Rifici, V. A., Gupta, S. K., Rie, J., Shan, Z., Neugarten, J., & Schlöndorff, D. (1991) · Kidney International · doi:10.1038/ki.1991.108 · Cited by 102
Park, Y. S., Guijarro, C., Kim, Y., Massy, Z. A., Kasiske, B. L., Keane, W. F., & Mp, O. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9428473 · Cited by 90
Apolipoprotein-B-Containing Lipoproteins and the Progression of Renal Insufficiency
Samuelsson, O. G., Aurell, M., Knight‐Gibson, C., et al. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000187210 · Cited by 81
Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy
Buemi, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.105330 · Cited by 78
Human mesangial cell production of monocyte chemoattractant protein-1: Modulation by lovastatin
Kim, S.-Y., Guijarro, C., O’Donnell, M. P., Kasiske, B. L., Kim, Y., & Keane, W. F. (1995) · Kidney International · doi:10.1038/ki.1995.304 · Cited by 74
Lipoprotein distribution and composition in the human nephrotic syndrom
Muls, E., Rosseneu, M., Daneels, R. F., Schurgers, M., & Boelaert, J. R. (1985) · Atherosclerosis · doi:10.1016/0021-9150(85)90181-9 · Cited by 70
Oxidative modification of low-density lipoproteins by mesangial cells.
Keane, W. F., O’Donnell, M. P., Kasiske, B. L., & Kim, Y. (1993) · Journal of the American Society of Nephrology · doi:10.1681/asn.v42187 · Cited by 70
Vrtovsnik, F., Couette, S., Prié, D., Lallemand, D., & Friedlander, G. (1997) · Kidney International · doi:10.1038/ki.1997.423 · Cited by 68
Lovastatin inhibits lipopolysaccharide-induced NF-kB activation in human mesangial cells
Guijarro, C., Kim, Y., Schoonover, C. M., Massy, Z. A., O’Donnell, M. P., Kasiske, B. L., Keane, W. F., & Kashtan, C. E. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.6.990 · Cited by 65
Sanjad, S. A., Al-Abbad, A., & Al-Shorafa, S. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70213-0 · Cited by 58
Interstitial foam cells and oxidized lipoprotein in human glomerular disease.
Ab, M. (1999) · PubMed · Cited by 55
Rayner, B. L., Byrne, M., & van Zyl-Smit, R. N. (1996) · PubMed · Cited by 53
Effects of flwastatin on growth of porcine and human vascular smooth muscle cells in vitro
Rogler, G., Lackner, K. J., & Schmitz, G. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(05)80031-1 · Cited by 45
Lipids in progression of renal disease.
Oda, H., & Keane, W. F. (1997) · PubMed · Cited by 40
Dell’Omo, G., Bandinelli, S., Penno, G., Pedrinelli, R., & Mariani, M. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.109787 · Cited by 35
Angiotensin II and oxidized LDL: an unholy alliance creating oxidative stress
Galle, J., & Heermeier, K. (1999) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/14.11.2585 · Cited by 29
Effects of Hypercholesterolemia on Renal Hemodynamics: Study in Patients with Nephrotic Syndrome
Fuíano, G., Esposito, C., Sepe, V., G., C., Bovino, M., Rosa, M., Balletta, M., Bellinghieri, G., Conte, G., Cianciaruso, B., et al. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000189106 · Cited by 20
Plasma levels of lipoprotein (a) do not predict progression of human chronic renal failure
Samuelsson, O. G., Attman, P.-O., Knight‐Gibson, C., Larsson, R., Mulec, H., Wedel, H., Weiss, L. G., & Alaupovic, P. (1996) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/11.11.2237 · Cited by 18
[Effect of pravastatin on hypercholesterolemia associated with proteinuria].
Arcas, J. L. A., Sánchez, R., Guijarro, C., Araque, A., Pulido, F., Praga, M., & Damiano, A. (1994) · PubMed · Cited by 10
Cited by
de Zeeuw, D., Remuzzi, G., Parving, H.-H., Keane, W. F., Zhang, Z., Shahinfar, S., Snapinn, S., Cooper, M. E., Mitch, W. E., & Brenner, B. M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00653.x · Cited by 975
Bax, L., Woittiez, A.-J. J., Kouwenberg, H. J., Mali, W. P. T. M., Buskens, E., Beek, F. J. A., Braam, B., Huysmans, F. T. M., Schultze Kool, L. J., Rutten, M. J. C. M., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-12-200906160-00119 · Cited by 706
Sirtori, C. R. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.002 · Cited by 691
Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences
Vaziri, N. D. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00099.2005 · Cited by 538
Obesity and Obesity-Initiated Metabolic Syndrome: Mechanistic Links to Chronic Kidney Disease
Wahba, I. M., & Mak, R. H. (2007) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04071206 · Cited by 513
Metadata
- Authors
- Bianchi, S., Bigazzi, R., Caiazza, A., & Campese, V. M.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2003-03
- Volume
- 41
- Issue
- 3
- Pages
- 565-570
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W1998747783
- Cited by
- 332
- References
- 38
- FWCI
- 18.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.